Premium
THE VALUE OF HPV DNA TYPING IN THE DISTINCTION BETWEEN ADENOCARCINOMAS OF ENDOCERVICAL AND ENDOMETRIAL ORIGIN IN BIOPSY MATERIAL
Author(s) -
M Plunkett,
B Brestovac,
G Sterrett,
J Thompson,
F Frost,
D Smith
Publication year - 2001
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1046/j.1440-1827.2001.00025.x
Subject(s) - adenocarcinoma , typing , cervix , medicine , pathology , biopsy , biology , cancer , genetics
and aims: Distinguishing between adenocarcinomas of endocervical and endometrial origin histologically can be difficult, particularly in curetting specimens with minimal material for examination. Endocervical adenocarcinomas have been shown to contain HPV DNA of certain ‘high risk’ subtypes, whereas this has not been consistently demonstrated in endometrial adenocarcinomas. The aims of this study were to look at whether HPV DNA typing could aid in this differential diagnosis. Methods: The study investigated the frequency of HPV DNA in paraffin embedded tissue samples from endocervical and endometrial adenocarcinoma specimens using PCR amplification techniques designed to detect HPV DNA including high risk subtypes 16, 18, 31, 33, 45 and 58. Cases were selected from PathCentre and King Edward Memorial Hospital files, mainly curetting specimens with subsequent definitive hysterectomy. All cases were reviewed by a gynaecological pathologist. Control specimens included CIN III lesions, squamous cell carcinomas (SCC's) of the cervix and lung, and colonic adenocarcinomas. Measures to prevent cross contamination were implemented. Results: HPV DNA was detected in 11 of 11 (100%) CIN III lesions, 9 of 10 (90%) cervical SCC's, 0 of 100 (0%) colorectal adenocarcinomas and 1 of 10 (10%) SCC's of the lung. 26 of 34 (76.5%) endocervical adenocarcinomas contain HPV DNA with 20 (55.6%) containing high risk subtypes, compared to 2 of 29 (6.9%) endometrial carcinomas, one with high risk subtype. Conclusions: Preliminary results suggest HPV DNA typing could be a useful adjunct in distinguishing between endocervical and endometrial adenocarcinomas on curetting specimens, and possibly in the diagnosis of metastatic carcinomas of the cervix.